PCA
GILD icon

Prosperity Capital Advisors’s Gilead Sciences GILD Stock Holding History

Prosperity Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
2,146
-7
-0.3% -$922 0.01% 359
2026
Q1 		$300K Buy
2,153
+322
+18% +$45.1K 0.02% 331
2025
Q4 		$225K Buy
+1,831
New +$223K 0.01% 359

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Prosperity Capital Advisors's GILD Position: Q2 2026 in Review

Prosperity Capital Advisors reduced its Gilead Sciences (GILD) stake by 0.33% in Q2 2026, selling an estimated $922 and leaving 2,146 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #359.

Prosperity Capital Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $300K in Q1 2026. 494 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prosperity Capital Advisors held 2,146 shares of Gilead Sciences worth $271K as of Q2 2026.
  • Prosperity Capital Advisors sold 7 Gilead Sciences shares in Q2 2026, an estimated $922.
  • Gilead Sciences made up 0.01% of Prosperity Capital Advisors's portfolio in Q2 2026, its #359 holding.
  • Prosperity Capital Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Prosperity Capital Advisors's Gilead Sciences position peaked at $300K in Q1 2026.
  • 494 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.